期刊文献+

结核病临床分离株及痰标本中embB基因型的快速测定 被引量:2

Rapid detection of embB genotype of Mycobacterium tuberculosis in clinical isolates and sputum
下载PDF
导出
摘要 目的建立快速测定结核病耐乙胺丁醇(EMB)分离株和痰标本中结核分枝杆菌EMB耐药基因型的方法,以期为患者提供及时、有效地化验结果。方法应用16SrDNA聚合酶链反应(PCR)-单链构象多态性(SSCP)和PCR-限制性片段长度多态性(RFLP)对11株耐EMB分离株和46例结核病痰标本进行分子菌种鉴定和embB基因突变的部位与性质分析。结果以结核分枝杆菌H37Rv标准株为对照,11株耐EMB分离株和46例临床痰标本经16SrDNAPCR-SSCP分析电泳图谱均与结核分枝杆菌标准株相同;限制性内切酶Nla消化embB基因扩增产物显示,11株耐EMB分离株中4株(36.4%)不被Nla消化;46例结核病痰标本中10例(21.7%)不被Nla消化。结论部分结核分枝杆菌耐EMB是由于embB基因突变所致,采用PCR-SSCP和PCR-RFLP方法可直接快速测定结核病耐EMB分离株和痰标本中结核分枝杆菌耐EMB基因型。 Objective To develop a rapid method for detection of ethambutol resistance genotype ^(embB) in Mycobacterium tuberculosis clinical isolates and sputa. Methods In order to ~identify tuberculosis species and find mutation position and characterization of embB gene, 11 clinical isolates and 46 sputa were analyzed with 16S rDNA-Polymerase chain reaction (PCR), PCR-Single stranded conformation polymorphism (PCR-SSCP) and PCR-Restrictive fraction length polymerase (PCR-RFLP). Results Mycobacterium tuberculosis isolate H37Rv was used as control, 11 clinical isolates and 46 sputa specimens were analyzed with PCR-SSCP, they had the same 16S rDNA profiles as M.tuberculosis standard strain. Of 11 ethambutol-resistant clinical isolates, 4(36.4%) had abnormal RFLP profiles. of 46 sputa specimens, 10 (21.7%) had abnormal RFLP profiles. Conclusion Ethambutol resistances in some Mycobacterium tuberculosis isolates were due to mutations on embB genes. PCR-SSCP and PCR-RFLP methods might become rapid and effective diagnostic test for genotype of M.tuberculosis ethambutol-resistance clinical isolates and sputa.
机构地区 解放军
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2005年第2期100-102,共3页 Chinese Journal of Antibiotics
关键词 聚合酶链反应 单链构象多态性 限制性片段长度多态性 乙胺丁醇 结核分枝杆菌 结核病 Polymerase chain reaction Single stranded conformation polymorphism Restrictive fraction length polymorphism Ethambutol Mycobacterium tuberculosis Tuberculosis
  • 相关文献

参考文献2

二级参考文献1

共引文献45

同被引文献16

  • 1鲍优红,叶建萍,葛超荣.用PCR法快速初筛结核分枝杆菌的耐多药性[J].江西医学检验,2004,22(5):429-430. 被引量:3
  • 2梁雅萍,黄治俊.结核耐药性现状调查及分析[J].实用医技杂志,2005,12(09A):2456-2457. 被引量:5
  • 3结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28-31. 被引量:799
  • 4王倩,闫忠芳,黄淑萍,吴琦,张丽霞.我国结核病耐药状况及其变化趋势分析[J].中国药房,2007,18(2):93-96. 被引量:17
  • 5马坞,朱莉贞,潘毓萱,主编.结核病.北京:人民卫生出版社,2006,593-595.
  • 6张翠英.结核病流行与控制进展.全国结核病诊治新技术新方法研讨班.新疆.如06年7月,26-33.
  • 7Sreevatsan S, Stockbauer KE, XiPan, et al. Ethambutol resistancein Mycobacterium tuberculosis : critical role of embB mutations. Antimicrob Agents Chemother, 1997,41 ( 8 ) : 1677.
  • 8World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO Report, 2006.
  • 9BELANGER A E, BESTRA G S, FORD M E, et al. The emb AB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosyn thesis that is the target for the antimycobacterial drug ethambutol [ J]. Proc NatL Acad Sci USA, 1996, 93 ( 12 ) : 11919-11924.
  • 10TELENTI A, PHILIPP W J, SREEVATSAN S, et al. The emb operon, a gene cluster of Mycobaclerium tuberculosis involved in resistance to ethambutol[J]. Nat Med, 1997,3( 1 ) :567-570.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部